Eye scan may predict MS disability risk early

Credibility

Interest

Key Takeaway

A thinner layer of nerve cells in the retina (measured once after MS starts) can help predict which people are more likely to have worse disability over the next few years.

What They Found

Researchers used an eye scan called OCT to measure the thickness of a retinal nerve layer (the ganglion cell layer) in 201 people soon after their first MS event. They found that people with a thickness at or below 77 micrometers were more likely to have signs of ongoing disease activity. Those with a thickness at or below 69 micrometers were more likely to have confirmed worsening of disability later on. Faster yearly loss of this retinal layer was linked to a higher chance of disability getting worse, like losing 1 micrometer per year raised the risk. Overall, a single OCT measurement soon after MS starts could help spot people at higher risk of future problems.

Who Should Care and Why

People with new or early relapsing MS should care because this eye scan might give an early warning about future disability, similar to a weather forecast that helps you prepare for a storm. Caregivers can use this information to push for closer follow-up or extra support if the scan shows a thinner layer. Neurologists and eye doctors might use this test to choose how closely to watch disease activity or to consider stronger treatment sooner. If you know you are at higher risk, you can plan practical steps like arranging home help, physical therapy, or more frequent check-ins. This is most useful for people early in their MS course, when decisions about treatment and monitoring are often being made.

Important Considerations

This study shows an association, not proof that the thin retinal layer causes worse disability; other factors could also matter. The results come from two centers in Germany and may not apply exactly the same to people with different backgrounds or care settings. Also, the OCT measurement is one tool among many—MRI, exams, and symptoms are still important for making treatment decisions.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics MS Progression Early Research

Article Topics:

disabilitymultiple sclerosisoptical coherence tomographyprognosis

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like European journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News